(Information sent by the signatory company)

– Biopharmaceutical leaders shape the future of drug development at Veeva European R&D & Quality Summit

Ascendis, Bayer, Boehringer Ingelheim, Jazz Pharmaceuticals, Novo Nordisk, Sanofi and Teva to present keynotes to share innovations to drive better outcomes for patients

BARCELONA, Spain, May 21, 2024 /PRNewswire/ — Veeva Systems (NYSE: VEEV) today announced that leaders from Ascendis Pharma A/S, Bayer, Boehringer Ingelheim, Jazz Pharmaceuticals, Novo Nordisk, Sanofi and Teva will be keynote speakers at the Veeva Quality and R&D Summit, Europe, June 4-5, in Madrid, Spain. Life sciences professionals from across the industry will come together to share how connected technologies across clinical, regulatory, safety and quality are driving innovations for patients.

As one of the largest gatherings of biopharmaceutical leaders in Europe, Veeva R

The event’s zone keynotes include:

A panel featuring Elpida Therapeutics CEO Terry Pirovolakis and experts from Veeva will close the event with a discussion on how the industry can best accelerate the development of life-saving gene therapies for rare diseases.

“Connecting clinical, regulatory, safety and quality is key to advancing the product lifecycle and delivering better patient outcomes,” said Rik Van Mol, senior vice president of Veeva Development Cloud. “At the Veeva Quality and R&D Summit, biopharmaceutical leaders can connect, exchange ideas and share new strategies to advance the industry together.”

The Veeva Quality and R&D Summit is open exclusively to life sciences professionals. Register and review the agenda at veeva.com/eu/Summit.

Additional informationConnect with Veeva on LinkedIn: linkedin.com/company/veeva-systems

About Veeva Systems Veeva is the global leader in cloud software for the life sciences industry. Committed to innovation, product excellence and customer success, Veeva serves more than 1,000 customers, from the world’s largest biopharmaceutical companies to emerging biotechnology companies. As a Public Benefit Corporation, Veeva is committed to balancing the interests of all stakeholders, including customers, employees, shareholders, and the industries it serves. For more information, visit veeva.com/eu.

Veeva Forward-Looking StatementsThis release contains forward-looking statements regarding Veeva’s products and services and the expected results or benefits from the use of our products and services. These statements are based on our current expectations. Actual results could differ materially from those provided in this release and we undertake no obligation to update such statements. There are numerous risks that have the potential to negatively impact our results, including the risks and uncertainties disclosed in our filing on Form 10-K for the fiscal year ended January 31, 2024, which can be found here (a summary of the risks that may impact our business can be found on pages 9 and 10) and in our subsequent filings with the SEC, which can be accessed at sec.gov.


Jeremy WhittakerVeeva Systems 49-695-095-5486jeremy.whittaker@veeva.com

Logo – https://mma.prnewswire.com/media/1488285…

View original content: https://www.prnewswire.com/news-releases/cumbre-europea-de-id-y-calidad-de-veeva-302151364.html